No Data
Express News | Delcath Systems Inc - No Significant Differences in Os, Orr, or Pfs Based on Extrahepatic Lesions
Express News | Delcath Systems Announces New Data Presented at Esmo 2024 Demonstrating Efficacy of Hepzato Kit™ in Metastatic Uveal Melanoma Subgroups
Delcath Systems Announces New Data Presented at ESMO 2024 Demonstrating Efficacy of HEPZATO KIT in Metastatic Uveal Melanoma Subgroups
Delcath Systems, Inc.'s (NASDAQ:DCTH) P/S Is Still On The Mark Following 26% Share Price Bounce
'This Is A Very Speculative Situation,' Jim Cramer On ADMA Biologics
Is Delcath Systems (NASDAQ:DCTH) Weighed On By Its Debt Load?